Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/OBI stock hub

AIM/OBI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/OBIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

72.7M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/OBI

In the news

Latest news · AIM/OBI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-6,414.8

P25 -54.2P50 2.1P75 13.7

ROIC-1,827.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/OBI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

CAD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	UK
Employees	18
Employees Change	-9%
Employees Change Percent	-33.33
Enterprise value	GBX 70.1M
Exchange	London Stock Exchange AIM
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA68234M2058
Last refreshed	2026-05-10
Market cap	GBX 72.7M
Price	GBX 14
Price currency	GBX
Rev Per Employee	65,499.11x
Sector	Healthcare
Sic	2834
Symbol	aim/OBI
Website	https://ondinebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.58%
EV Earnings	-5.48x
EV/FCF	-7.04x
EV/Sales	59.42x
FCF yield	-13.69%
P/B ratio	187.21x
P/S ratio	61.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	65.77%
Gross Profit	GBX 775,465
Gross Profit Growth	9.69%
Gross Profit Growth Q	24.2%
Gross Profit Growth3 Y	27.26%
Gross Profit Growth5 Y	38.24%
Net Income	GBX -12.8M
Net Income Growth Years	0%
Pretax Margin	-1,084.66%
Profit Per Employee	GBX -710,441
ROA	-236
ROCE	-2,475.3
ROE	-6,414.8
ROIC	-1,827.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	55.6%
Cagr3y	-9.68%
EPS Growth Years	3
Revenue Growth	34.82x
Revenue Growth Q	17.93x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	22.34x
Revenue Growth5 Y	28.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.34
Assets	GBX 4.7M
Cash	GBX 3M
Current Assets	GBX 4M
Current Liabilities	GBX 4.2M
Debt	GBX 297,021
Debt Equity	GBX 0.76
Debt FCF	GBX -0.03
Equity	GBX 388,535
Interest Coverage	-2,011.2
Liabilities	GBX 4.3M
Long Term Assets	GBX 656,882
Long Term Liabilities	GBX 122,401
Net Cash	GBX 2.7M
Net Cash By Market Cap	GBX 3.69
Net Cash Growth	478.2%
Net Debt Equity	GBX -6.9
Tangible Book Value	GBX 388,535
Tangible Book Value Per Share	GBX 0
WACC	5.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.97
Inventory Turnover	0.58
Net Working Capital	GBX -3M
Quick ratio	0.76
Working Capital	GBX -145,567
Working Capital Turnover	GBX -2.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-68.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	55.56%
200-day SMA	11.76
3Y total return	-26.32%
50-day SMA	11.2
50-day SMA vs 200-day SMA	50under200
All Time High	60
All Time High Change	-76.67%
All Time High Date	2021-12-15
All Time Low	5
All Time Low Change	180%
All Time Low Date	2024-05-03
ATR	0.92
Beta	0.27
Beta1y	-0.05
Beta2y	0.1
Ch YTD	60
High	14.45
High52	18.5
High52 Date	2025-08-19
High52ch	-24.32%
Low	13
Low52	7.5
Low52 Date	2026-01-21
Low52ch	86.67%
Ma50ch	24.98%
Price vs 200-day SMA	19.08%
RSI	83.63
RSI Monthly	51.63
RSI Weekly	67.6
Sharpe ratio	1.08x
Sortino ratio	2.03
Total Return	-68.94%
Tr YTD	60
Tr1m	33.33%
Tr1w	19.15%
Tr3m	55.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -12.9M
Operating margin	-1,095.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	316,787,274%
Net Borrowing	372,377.5
Shares Insiders	21.48%
Shares Institutions	31.97%
Shares Out	519,551,468
Shares Qo Q	42.09%
Shares Yo Y	68.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -11.1M
Average Volume	623,307.6x
Bv Per Share	0
CAPEX	GBX -12,844
Ch1m	33.33
Ch1w	19.15
Ch1y	55.56
Ch3m	55.56
Ch3y	-26.32
Ch6m	14.29
Change	2.94%
Change From Open	0.79
Close	13.6
Days Gap	2.13
Depreciation Amortization	225,358.2
Dollar Volume	16,474,654
Earnings Date	2026-05-21
EBIT	GBX -12.9M
EBITDA	GBX -12.7M
EPS	GBX -0.03
F Score	3
FCF	GBX -10M
FCF EV Yield	-14.21x
FCF Per Share	GBX -0.02
Financing CF	11,764,691
Fiscal Year End	December
Founded	1,996
Investing CF	-12,844
Is Primary Listing	1
Last Earnings Date	2025-12-24
Last Report Date	2025-06-30
Ma150	10.76
Ma150ch	30.11%
Ma20	12.02
Ma20ch	16.49%
Net CF	2,246,653
Next Earnings Date	2026-05-21
Open	13.89
Position In Range	68.97
Ppne	649,782.7
Price Date	2026-05-08
Ptbv Ratio	187.2
Relative Volume	1.94x
Revenue	1,178,984x
SBC By Revenue	100.82x
Share Based Comp	1,188,618
Tr6m	14.29%
Volume	1,176,761
Z Score	-51.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/OBI pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/OBI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/OBI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.0%

Share of float held by funds and institutions

Insider ownership

+21.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+68.9%

Negative means the company is buying back shares.

Technical

AIM/OBI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

83.6

Above 70: short-term overbought

Price vs 200-day MA

+19.1%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/OBI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/OBI stock rating?

aim/OBI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/OBI analysis?

The full report lives at /stocks/aim/OBI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/OBI?

The latest report frames aim/OBI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/OBI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.